To advance urologic care through computational and functional genomics:
– Deciphering mechanisms of response and resistance to therapy
– Establishing new models to define gene function and cell phenotypes
– Fostering a new generation of computational urologists
We are looking forward to growing our lab and community. If you want to learn more about our work, please reach out to us!
01.24.2024 Kate selected to present her single cell work at American Association for Cancer Research (AACR) Annual Meeting
01.19.2024 Filipe is the 2023 awardee of the BCAN Bladder Cancer Career Development Award
12.19.2023 Chris’s work selected for presentation at European Association of Urology Annual meeting in Paris
11.06.2023 Filipe promoted to Assistant Professor of Surgery, Harvard Medical School
05.31.2023 Konrad’s work presented at ASCO Annual Meeting
04.20.2023 Welcome Kate!
I was thrilled to meet with all three cohorts of @theNCI’s Early-Stage Surgeon Scientist Program earlier today! They're an essential part of the future of cancer research, with a rare, unique blend of practical expertise and scientific acuity. https://go.nih.gov/yI2M698
Dr. Filipa Lynce (@FilipaLynce) and colleagues recently published a study showing that T cells instruct immune checkpoint inhibitor therapy resistance in tumors responsive to IL-1 and TNFα Inflammation.
https://pubmed.ncbi.nlm.nih.gov/39404741/
Join us on Saturday 11/9 at 10am for our 7th IBC Patient Forum to hear from the Director of the Dana Farber IBC Program @Filipa Lynce on What Makes IBC Unique: Biology, Management and Ongoing Research Initiatives. https://redcap.link/DanaFarberIBCForum2024